The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).

Nuclear Medicine and Biology
Marc B SkaddanAnabella Villalobos

Abstract

Fatty acid amide hydrolase (FAAH) is responsible for the enzymatic degradation of the fatty acid amide family of signaling lipids, including the endogenous cannabinoid (endocannabinoid) anandamide. The involvement of the endocannabinoid system in pain and other nervous system disorders has made FAAH an attractive target for drug development. Companion molecular imaging probes are needed, however, to assess FAAH inhibition in the nervous system in vivo. We report here the synthesis and in vivo evaluation of [(18)F]PF-9811, a novel PET ligand for non-invasive imaging of FAAH in the brain. The potency and selectivity of unlabeled PF-9811 were determined by activity-based protein profiling (ABPP) both in vitro and in vivo. [(18)F]PF-9811 was synthesized in a 3-step, one-pot reaction sequence, followed by HPLC purification. Biological evaluation was performed by biodistribution and dynamic PET imaging studies in male rats. The specificity of [(18)F]PF-9811 uptake was evaluated by pre-administration of PF-04457845, a potent and selective FAAH inhibitor, 1h prior to radiotracer injection. Biodistribution studies show good uptake (SUV~0.8 at 90 min) of [(18)F]PF-9811 in rat brain, with significant reduction of the radiotracer in all br...Continue Reading

References

Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y LiuB F Cravatt
Dec 7, 2000·Chemistry and Physics of Lipids·N UedaD G Deutsch
Feb 24, 2001·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·A A WilsonS Houle
Apr 12, 2002·Current Medicinal Chemistry·Didier M LambertChristopher J Fowler
Jun 15, 2005·Annual Review of Biochemistry·Michele K McKinney, Benjamin F Cravatt
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Mar 28, 2008·Annual Review of Biochemistry·Benjamin F CravattJohn W Kozarich
Apr 24, 2008·Chemical Reviews·Kay AhnBenjamin F Cravatt
May 1, 2008·Nature Reviews. Drug Discovery·Vincenzo Di Marzo
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Mauro MileniRaymond C Stevens
Nov 6, 2008·Journal of Medicinal Chemistry·Mark Seierstad, J Guy Breitenbucher
Jun 15, 2010·Expert Opinion on Drug Discovery·Kay AhnBenjamin F Cravatt
Sep 8, 2010·Bioorganic & Medicinal Chemistry Letters·Cyrine EzziliDale L Boger
Nov 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daniel A BachovchinBenjamin F Cravatt
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xiaoshan MinZhulun Wang
Jun 15, 2011·ACS Medicinal Chemistry Letters·Douglas S JohnsonKay Ahn

❮ Previous
Next ❯

Citations

Jun 7, 2014·Annual Review of Biochemistry·Micah J Niphakis, Benjamin F Cravatt
Mar 20, 2013·Nature Chemical Biology·Gabriel M SimonBenjamin F Cravatt
Oct 3, 2014·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Timothy M ShoupNeil Vasdev
Dec 12, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Jason P HollandNeil Vasdev
Sep 21, 2017·Molecular Imaging·Brian P RempelChristopher P Phenix
May 16, 2013·Chemical Communications : Chem Comm·Benjamin H RotsteinNeil Vasdev
Apr 17, 2013·Clinical Pharmacology and Therapeutics·P A MilliganR L Lalonde
Jul 9, 2014·Molecular Pharmaceutics·Benjamin H RotsteinNeil Vasdev
Jun 6, 2014·ACS Medicinal Chemistry Letters·Ping LiuRobert J DeVita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here